Filter Results :

Your search for Diseases returned 222 reports

Sort by


Blood Collection Market by Product (Syringes, Needles, EDTA, Heparin, Serum, Tubes, Blood Lancets, Blood Bags, Vials), Application (Diagnostic, Treatment, Infectious Diseases, Non Infectious Diseases) & End User (Blood Banks, Hospitals) - Forecast to 2021

26 Jul 2016  |  Published by:  MarketsandMarkets
The blood collection market is expected reach USD 9.90 billion by 2021 from USD 7.65 billion in 2016, at CAGR of 5.3% from 2016 to 2021. Factors such as increasing number of surgical procedures requiring blood transfusions, rising prevalence of diseases, and growing number of accidental and tr...

$ 5,650.00

Read More

Global Infectious Diseases Partnering 2010-2016: Deal trends, players and financials

01 Jul 2016  |  Published by:  CurrentPartnering
Global Infectious Diseases Partnering 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the infectives partnering deals and agreements entered into by the worlds leading healthcare companies.Global Infectious Diseases Partnering 20...

$ 3,495.00

Read More

Global Sexually Transmitted Diseases Partnering 2010-2016

01 Jul 2016  |  Published by:  CurrentPartnering
Provides understanding and access to the sexually transmitted diseases partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreeme...

$ 1,495.00

Read More

Global Orphan Diseases Partnering 2010-2016: Deal trends, players and financials

01 Jul 2016  |  Published by:  CurrentPartnering
The Global Orphan Diseases Partnering 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the orphan diseases partnering deals and agreements entered into by the worlds leading healthcare companies.Global Orphan Diseases Partnering 2...

$ 2,995.00

Read More

KSPH - Kaifeng Hospital for Infectious Diseases - Henan - Construction Project Profile

29 Jun 2016  |  Published by:  Timetric
Synopsis"KSPH Kaifeng Hospital for Infectious Diseases Henan - Construction Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on...

$ 75.00

Read More

Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other Diseases

03 Jun 2016  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence report about Bispecific Antibodies for Cancer, Inflammatory & Other Diseases evaluates the competitive landscape of bispecific therapeutic antibodies for treatment of cancer, anti-inflammatory & autoimmune diseaseas as well as cardiometabolic, infectious, ...

$ 555.83

Read More

Microbiology Testing/Clinical Microbiology Market by Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), Clinical Application (Respiratory Diseases, STD, UTI), Product (instruments, Analyzers, Consumables) - Global Forecasts to 2021

03 Jun 2016  |  Published by:  MarketsandMarkets
The global clinical microbiology market is projected to reach USD 5.77 billion by 2021 from USD 3.35 billion in 2016, growing at a CAGR of 11.5%, during 2016 to 2021. Market growth can be attributed to factors such as the technological advancements; rising incidence of infectious diseases and ...

$ 5,650.00

Read More

Superdisintegrants Market by Product (Croscarmellose Sodium, Crospovidone, Sodium Starch Glycolate, Ion Exchange Resins), Application (Tablets, Capsules), Therapeutic Area (Oncology, Neurology, Cardiology, Infectious Diseases) - Global Forecast to 2021

01 Jun 2016  |  Published by:  MarketsandMarkets
The global superdisintegrants market is expected to grow at a CAGR of 7.8% during the forecast period from 2016 to 2021. The market is poised to reach USD 416.5 million by 2021 from USD 286.8 million in 2016. The market is primarily driven by growing generic drugs market, growing population of...

$ 4,650.00

Read More

Medical Gases Market by Gases (Oxygen, Nitrogen, Nitrous Oxide, Helium, Gas Mixture), Equipment (Delivery System, Cryogenic Freezer, Oxygen Concentrator), Application (Respiratory Diseases, Anesthesia, Medical Imaging) & by End User - Global Forecast to 2021

18 Apr 2016  |  Published by:  MarketsandMarkets
The global medical gases and equipment market is poised to reach USD 19.96 billion by 2021 from USD 13.58 billion in 2016, at a CAGR of 8.0% during the forecast period. The market is primarily driven by the implementation of the U.S. Food and Drug Administration (FDA) Safety and Innovation act...

$ 7,150.00

Read More

The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile

17 Mar 2016  |  Published by:  GlobalData
SummaryThe National Institute of Allergy and Infectious Diseases (NIAID), a subsidiary of National Institutes of Health is a research institute that develops therapies, vaccines, diagnostic tests and other technologies to understand, treat and prevent infectious, immunologic and allergic diseases. T...

$ 250.00

Read More

U.S. In Vitro Diagnostics (IVD) Market by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology), Application (Infectious Diseases, Diabetes, Cancer, Cardiology), End User (Hospitals & Laboratories) & by Region - Forecast to 2020

17 Mar 2016  |  Published by:  MarketsandMarkets
In vitro diagnostics testing is an indispensable tool in the modern medical practice. IVD tests are conducted with the help of various medical devices for the diagnosis of a number of diseases. With evolution in biotechnology, there has been a drastic change in the type of tests conducted for ...

$ 12,000.00

Read More

Rising Stars: New Emergence Of Potential TX & DX Options Could Transform The Current Landscape For Liver Diseases (Nash)

01 Feb 2016  |  Published by:  MP Advisors
Non-Alcoholic SteatoHepatitis (NASH) is an unmet medical need and is becoming the leading cause of liver transplant. No FDA-approved therapies and a meager diagnosis, it poses a unique challenge in the design of studies for NASH. Therefore, there is a worldwide need for new therapies to treat ...

$ 2,000.00

Read More

Graves Diseases Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jan 2016  |  Published by:  DelveInsight
Summary'Graves Diseases- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufac...

$ 2,000.00

Read More

Inflammatory Skin Diseases Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jan 2016  |  Published by:  DelveInsight
Summary'Inflammatory Skin Diseases- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for ...

$ 2,000.00

Read More

Inflammatory Skin Diseases-Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary Inflammatory Skin Diseases- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Inflammatory Skin Diseases. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing a...

$ 1,250.00

Read More
Total 222 records.